Pređi na sadržaj

Датотека:Cross-reactivity hypothesis for the onset of dermatitis herpetiformis in patients with celiac disease.tif

Sadržaj stranice nije podržan na drugim jezicima
Ovo je datoteka sa Vikimedijine ostave
S Vikipedije, slobodne enciklopedije

Originalna datoteka(1.962 × 931 piksela, veličina datoteke: 442 kB, MIME tip: image/tiff)

Opis izmene

Opis
English: Gliadin proteins in gluten are absorbed by the gut and enter the lamina propria where they need to be deamidated by tissue transglutanimase (tTG). tTG modifies gliadin into a more immunogenic peptide. Classical dendritic cells (cDCs) endocytose the immunogenic peptide and if their pattern recognition receptors (PRRs) are stimulated by pathogen-associated molecular patterns (PAMPs) or danger-associated molecular pattern (DAMPs), the danger signal will influence them to secrete IL-8 (CXCL8) in the lamina propria, recruiting neutrophils. Neutrophil recruitment results in a very rapid onset of inflammation. Therefore, co-infection with microbes that carry PAMPs may be necessary for the initial onset of symptoms in gluten sensitivity, but would not be necessary for successive encounters with gluten due to the production of memory B and T cells (discussed below). In celiac disease, tTG is treated as an autoantigen, especially in people with certain HLA-DQ2 and HLA-DQ8 alleles and other gene variants that cause atopy. tTG is up-regulated after gluten absorption. cDCs endocytose tTG-modified gliadin complexes or modified gliadin alone but they only present gliadin to CD4+ T cells on pMHC-II complexes. These T cells become activated and polarised into type I helper T (Th1) cells. Th1 cells against gliadin have been discovered, but none against tTG. A naive B cell sequesters tTG-modified gliadin complexes from the surface of cDCs in the lymph nodes (LNs) before they become endocytosed by the cDCs. The B cell receptor (membrane bound antibody; BCR) is specific to the tTG portion of the complex. The B cell endocytoses the complex and presents the modified gliadin to the activated Th1 cell's T cell receptor (TCR) via pMHC-II. Thus, the B cell presents the foreign peptide (modified gliadin) but produces antibodies specific for the self-antigen (tTG). Once the B cell becomes activated, it differentiates into plasma cells that secrete autoantibodies against tTG, which may be cross-reactive with epidermal transglutanimase (eTG). Class A antibodies (IgA) deposit in the gut. Some may bind to the CD89 (FcaRI) receptor on macrophages (M1) via their Fc region (constant region). This will trigger endocytosis of the tTG-IgA complex, resulting in the activation of macrophages. Macrophages secrete more IL-8, propagating the neutrophil-mediated inflammatory response. In dermatitis herpetiformis, the purportedly cross-reactive autoantibodies may migrate to the skin. IgA deposits may form if the antibodies cross-react with epidermal transglutanimase (eTG). Macrophages may be stimulated to secrete IL-8 by the same process as is seen in the gut, causing neutrophils to accumulate at sites of high eTG concentrations in the dermal papillae of the skin. Neutrophils produce puss in the dermal papillae, generating characteristic blisters. IL-31 accumulation at the blisters may intensify itching sensations. Memory B and T cells may become activated in the absence of PAMPs and DAMPs during successive encounters with tTG-modified gliadin complexes or modified gliadin alone, respectively. Symptoms of dermatitis herpetiformis are often resolved if patients avoid a gluten-rich diet.
Datum
Izvor Sopstveno delo
Autor LBNBM OBIBT

Licenciranje

Ja, nosilac autorskog prava nad ovim delom, objavljujem isto pod sledećom licencom:
w:sr:Krijejtiv komons
autorstvo deliti pod istim uslovima
Dozvoljeno je:
  • da delite – da umnožavate, raspodeljujete i prenosite delo
  • da prerađujete – da preradite delo
Pod sledećim uslovima:
  • autorstvo – Morate da date odgovarajuće zasluge, obezbedite vezu ka licenci i naznačite da li su izmene napravljene. Možete to uraditi na bilo koji razuman manir, ali ne na način koji predlaže da licencator odobrava vas ili vaše korišćenje.
  • deliti pod istim uslovima – Ako izmenite, preobrazite ili dogradite ovaj materijal, morate podeliti svoje doprinose pod istom ili kompatibilnom licencom kao original.

Natpisi

Dodajte objašnjenje u jednom redu o tome šta ova datoteka predstavlja

Stavke prikazane u ovoj datoteci

prikazuje

Neka vrednost bez stavke na projektu Vikipodaci

skraćeno ime autora Serbian (transliteracija): LBNBM OBIBT
Vikimedija Serbian (transliteracija): LBNBM OBIBT

status autorskog prava Serbian (transliteracija)

zaštićeno autorskim pravima Serbian (transliteracija)

17. novembar 2017

izvor datoteke Serbian (transliteracija)

sopstveno delo Serbian (transliteracija)

kontrolna suma Serbian (transliteracija)

629d523e18e3d53b5614f5cf0a6819e137469cc5

veličina podatka Serbian (transliteracija)

452.162 bajt

visina Serbian (transliteracija)

931 piksel

širina Serbian (transliteracija)

1.962 piksel

Istorija datoteke

Kliknite na datum/vreme da biste videli tadašnju verziju datoteke.

Datum/vremeMinijaturaDimenzijeKorisnikKomentar
trenutna19:53, 17. novembar 2017.Minijatura za verziju na dan 19:53, 17. novembar 2017.1.962 × 931 (442 kB)LBNBM OBIBTUser created page with UploadWizard

Sledeća stranica koristi ovu datoteku:

Globalna upotreba datoteke

Drugi vikiji koji koriste ovu datoteku:

Metapodaci